Trial Review

Reset your password and enable multi-factor authentication (MFA)


For ANZCTR account holders: to help ensure the cyber safety of your account, you’ll need to reset your password and set-up multi-factor authentication (MFA) as per the instructions below.


  1. Go to the Login page, click ‘reset password’ and follow the instructions.
  2. Check your email for the link to set a new password.
  3. Create a new password that meets requirements. New passwords must include at least one lowercase letter, one uppercase letter, one number and one special character (e.g. !#$%&@).
  4. Return to the Login page and enter your new password. A verification code will be sent to your email.
  5. Check your email for the code and enter it on the Login page. If the code is entered incorrectly, you can re-enter the correct one or request a new one.

Learn more about MFA and its importance on the Australian Signals Directorate website.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT01925430




Registration number
NCT01925430
Ethics application status
Date submitted
15/08/2013
Date registered
19/08/2013
Date last updated
2/05/2014

Titles & IDs
Public title
The Evaluation of a New Sleep Algorithm
Scientific title
The Evaluation of a New Sleep/Wake State Algorithm
Secondary ID [1] 0 0
MA06082013
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Healthy 0 0
Condition category
Condition code

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Treatment: Devices - Screening device
Treatment: Devices - Comparative product

Comparative product - A device which monitors sleep/wake states

Screening device - This device will screen for sleep-breathing disorders


Treatment: Devices: Screening device
Non-invasive device worn over clothes during sleep. Used to screen for sleep-disordered breathing conditions.

Treatment: Devices: Comparative product
A non-invasive device worn on the arm or leg. It monitors body movement and sleep/wake states
Intervention code [1] 0 0
Treatment: Devices
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Total sleep time
Timepoint [1] 0 0
12 hrs
Secondary outcome [1] 0 0
Frequency of arousals during sleep
Timepoint [1] 0 0
12 hrs
Secondary outcome [2] 0 0
Duration of arousals during sleep
Timepoint [2] 0 0
12 hrs
Secondary outcome [3] 0 0
Occurrence of arousals during sleep
Timepoint [3] 0 0
12 hrs

Eligibility
Key inclusion criteria
* => 18yrs old
* can read and write English
* Provide informed written consent
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
* Unable to participate for the full duration of the study
* An individual who is deemed unsuitable to participate in the opinion of the investigator

Study design
Purpose
Duration
Selection
Timing
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/11/2013
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
1/02/2014
Sample size
Target
Accrual to date
Final
36
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 0 0
RedMed Ltd - Sydney
Recruitment postcode(s) [1] 0 0
2153 - Sydney

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
ResMed
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Klaus Schindhelm, BE PhD
Address 0 0
The University of New South Wales, Australia & ResMed Ltd
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.

Results not provided in https://clinicaltrials.gov/study/NCT01925430